The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation - PubMed (original) (raw)
- PMID: 7039877
- PMCID: PMC1536329
Review
The bone marrow: the major source of serum immunoglobulins, but still a neglected site of antibody formation
R Benner et al. Clin Exp Immunol. 1981 Oct.
Abstract
Immunoglobulin (Ig) secreting cells occur in all lymphoid tissues, including the bone marrow (BM). There are important differences between the various organs with respect to their number of Ig-secreting cells and the heavy chain isotype distribution of the secreted Igs. Furthermore, both distribution patterns depend on age. Early in life most Ig-secreting cells are localized in spleen and lymph nodes. In adults, however, the majority of all Ig-secreting cells of the individual are localized in the BM. Immunization can lead to the appearance of substantial numbers of antibody-forming cells in BM. The kinetics of the BM response are different from the response in the peripheral lymphoid tissues. Shortly after immunization most antibody-forming cells occur in the peripheral lymphoid tissues, but later on, especially during secondary type responses, most antibody-forming cells are localized in the BM. Apparently, antibody formation is regulated in such a way that peripheral lymphoid tissues respond rapidly, but only for a short period, whereas the BM response starts slowly, but takes care of a long-lasting massive production of antibodies to antigens which repeatedly challenge the organism.
Similar articles
- Antigen-secreting cells: enumeration of immunoglobulin-allotype-secreting cells in nonimmunized rabbits by means of hybrid-antibody-coated erythrocytes in a reverse hemolytic plaque assay.
Molinaro GA, Maron E, Dray S. Molinaro GA, et al. Proc Natl Acad Sci U S A. 1974 Apr;71(4):1229-33. doi: 10.1073/pnas.71.4.1229. Proc Natl Acad Sci U S A. 1974. PMID: 4133847 Free PMC article. - Ontogeny of humoral immune function in normal chickens: a comparison of immunoglobulin-secreting cells in bone marrow, spleen, lungs and intestine.
Lawrence EC, Arnaud-Battandier F, Grayson J, Koski IR, Dooley NJ, Muchmore AV, Blaese RM. Lawrence EC, et al. Clin Exp Immunol. 1981 Mar;43(3):450-7. Clin Exp Immunol. 1981. PMID: 7026091 Free PMC article. - Active suppression of immunoglobulin allotype synthesis. II. Transfer of suppressing factor with spleen cells.
Jacobson EB, Herzenberg LA, Riblet R, Herzenberg LA. Jacobson EB, et al. J Exp Med. 1972 May 1;135(5):1163-76. doi: 10.1084/jem.135.5.1163. J Exp Med. 1972. PMID: 4623317 Free PMC article. - Development of immuneeoglobulin and antibody-forming cells in different stages of the immun response.
Avrameas S, Antoine JC, Ternynck T, Petit C. Avrameas S, et al. Ann Immunol (Paris). 1976 Jun-Jul;127(3-4):551-71. Ann Immunol (Paris). 1976. PMID: 60908 Review. - Aging of the lymphoid system at the organ level. With special reference to the bone marrow as site of antibody production.
Benner R, Haaijman JJ. Benner R, et al. Dev Comp Immunol. 1980 Fall;4(4):591-603. doi: 10.1016/s0145-305x(80)80062-0. Dev Comp Immunol. 1980. PMID: 7002651 Review. No abstract available.
Cited by
- Unique and redundant roles of mouse BCMA, TACI, BAFF, APRIL, and IL-6 in supporting antibody-producing cells in different tissues.
Eslami M, Schuepbach-Mallepell S, Diana D, Willen L, Kowalczyk-Quintas C, Desponds C, Peter B, Vigolo M, Renevey F, Donzé O, Luther SA, Yalkinoglu Ö, Alouche N, Schneider P. Eslami M, et al. Proc Natl Acad Sci U S A. 2024 Jul 16;121(29):e2404309121. doi: 10.1073/pnas.2404309121. Epub 2024 Jul 11. Proc Natl Acad Sci U S A. 2024. PMID: 38990948 - Temporal dynamics and genomic programming of plasma cell fates.
Manakkat Vijay GK, Zhou M, Thakkar K, Rothrauff A, Chawla AS, Chen D, Lau LC, Gerges PH, Chetal K, Chhibbar P, Fan J, Das J, Joglekar A, Borghesi L, Salomonis N, Xu H, Singh H. Manakkat Vijay GK, et al. Nat Immunol. 2024 Jun;25(6):1097-1109. doi: 10.1038/s41590-024-01831-y. Epub 2024 May 2. Nat Immunol. 2024. PMID: 38698087 - Intradermal Vaccination against Influenza with a STING-Targeted Nanoparticle Combination Adjuvant Induces Superior Cross-Protective Humoral Immunity in Swine Compared with Intranasal and Intramuscular Immunization.
Hernandez-Franco JF, Yadagiri G, Patil V, Bugybayeva D, Dolatyabi S, Dumkliang E, Singh M, Suresh R, Akter F, Schrock J, Renukaradhya GJ, HogenEsch H. Hernandez-Franco JF, et al. Vaccines (Basel). 2023 Nov 7;11(11):1699. doi: 10.3390/vaccines11111699. Vaccines (Basel). 2023. PMID: 38006031 Free PMC article. - COVID-19 and plasma cells: Is there long-lived protection?
Nguyen DC, Lamothe PA, Woodruff MC, Saini AS, Faliti CE, Sanz I, Lee FE. Nguyen DC, et al. Immunol Rev. 2022 Aug;309(1):40-63. doi: 10.1111/imr.13115. Epub 2022 Jul 8. Immunol Rev. 2022. PMID: 35801537 Free PMC article. Review. - Instructing durable humoral immunity for COVID-19 and other vaccinable diseases.
Bhattacharya D. Bhattacharya D. Immunity. 2022 Jun 14;55(6):945-964. doi: 10.1016/j.immuni.2022.05.004. Epub 2022 May 10. Immunity. 2022. PMID: 35637104 Free PMC article. Review.
References
- J Exp Med. 1962 Sep 1;116:295-310 - PubMed
- J Immunol. 1975 Aug;115(2):579-83 - PubMed
- Immunochemistry. 1965 Dec;2(4):329-36 - PubMed
- Immunology. 1974 Nov;27(5):747-60 - PubMed
- Clin Immunol Immunopathol. 1978 Jan;9(1):111-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources